BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Paliperidone palmitate (Invega Sustenna) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Paliperidone palmitate (Invega Sustenna)\
 , from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07493551-9200@assetmemo.bio
DTSTAMP:20261121T005038Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Paliperidone palmitate (Invega Sustenna): Phase na readout est. (NC
 T07493551)
DESCRIPTION:Paliperidone palmitate (Invega Sustenna)\, phase na\, Schizophr
 enia.\nStudy: A Bioequivalence Study of PP3M in Patients With Schizophreni
 a\nEstimated primary completion: 31 December 2026. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/paliperidone-palmitate-invega-sustenna#upcom
 ing-events\nRegistry record: https://clinicaltrials.gov/study/NCT07493551
URL:https://assetmemo.bio/drug/paliperidone-palmitate-invega-sustenna#upcom
 ing-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
